McAdam LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,643
| Closed | -$1.88M | – | 376 |
|
|
2024
Q4 | $1.88M | Sell |
2,643
-1
| -0% | -$712 | 0.1% | 103 |
|
|
2024
Q3 | $2.78M | Sell |
2,644
-19
| -0.7% | -$20K | 0.16% | 78 |
|
|
2024
Q2 | $2.8M | Sell |
2,663
-26
| -1% | -$27.3K | 0.17% | 71 |
|
|
2024
Q1 | $2.59M | Buy |
2,689
+4
| +0.1% | +$3.85K | 0.17% | 73 |
|
|
2023
Q4 | $2.36M | Sell |
2,685
-8
| -0.3% | -$7.03K | 0.17% | 73 |
|
|
2023
Q3 | $2.22M | Buy |
2,693
+9
| +0.3% | +$7.41K | 0.18% | 69 |
|
|
2023
Q2 | $1.93M | Buy |
2,684
+17
| +0.6% | +$12.2K | 0.16% | 79 |
|
|
2023
Q1 | $2.19M | Sell |
2,667
-94
| -3% | -$77.2K | 0.2% | 74 |
|
|
2022
Q4 | $1.74M | Buy |
2,761
+86
| +3% | +$54.3K | 0.17% | 62 |
|
|
2022
Q3 | $1.84M | Buy |
2,675
+1
| +0% | +$689 | 0.2% | 74 |
|
|
2022
Q2 | $1.58M | Sell |
2,674
-88
| -3% | -$52K | 0.17% | 80 |
|
|
2022
Q1 | $1.93M | Buy |
2,762
+1
| +0% | +$698 | 0.18% | 66 |
|
|
2021
Q4 | $1.74M | Buy |
2,761
+1
| +0% | +$632 | 0.17% | 62 |
|
|
2021
Q3 | $1.67M | Sell |
2,760
-585
| -17% | -$354K | 0.19% | 62 |
|
|
2021
Q2 | $1.95M | Buy |
+3,345
| New | +$1.95M | 0.22% | 58 |
|
|
2018
Q4 | – | Sell |
-33
| Closed | -$13K | – | 474 |
|
|
2018
Q3 | $13K | Hold |
33
| – | – | ﹤0.01% | 312 |
|
|
2018
Q2 | $11K | Hold |
33
| – | – | ﹤0.01% | 322 |
|
|
2018
Q1 | $11K | Buy |
+33
| New | +$11K | 0.01% | 319 |
|